Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.57 USD | -11.70% | -14.66% | -14.54% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ken Berlin
CEO | Chief Executive Officer | 59 | 18-03-31 |
Roy Golan
DFI | Director of Finance/CFO | 50 | 23-10-18 |
Shmuel Tuvia
CTO | Chief Tech/Sci/R&D Officer | - | 22-04-30 |
General Counsel | - | 17-12-31 | |
Human Resources Officer | - | 18-12-31 | |
Dana Gelbaum
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Sidransky
CHM | Chairman | 64 | 17-10-31 |
Roni Appel
BRD | Director/Board Member | 57 | 04-10-31 |
Murray Goldberg
BRD | Director/Board Member | 79 | 17-11-30 |
Robert Spiegel
BRD | Director/Board Member | 73 | 17-11-30 |
Pini Orbach
BRD | Director/Board Member | - | 23-10-18 |
Ken Berlin
CEO | Chief Executive Officer | 59 | 18-03-31 |
Director/Board Member | 53 | 20-07-31 | |
Bridget Martell
BRD | Director/Board Member | 58 | 23-10-18 |
Yuval Cabilly
BRD | Director/Board Member | 44 | 23-10-18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 42,683,631 | 42,632,547 ( 99.88 %) | 50,231 ( 0.1177 %) | 99.88 % |
Company contact information
Ayala Pharmaceuticals, Inc.
9 Deer Park Drive Suite K-1
08852, Monmouth Junction
+
http://www.ayalapharma.comSector
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.54% | 28.1M | |
-1.82% | 41.35B | |
+42.61% | 40.38B | |
+2.56% | 39.05B | |
-12.11% | 26.67B | |
+3.09% | 24.07B | |
-24.16% | 18.36B | |
+22.12% | 11.6B | |
-3.74% | 11.68B | |
+7.75% | 11.15B |
- Stock Market
- Equities
- ADXS Stock
- Company Ayala Pharmaceuticals, Inc.